ArticleOphthalmology science

CANBERRA: A Phase II Randomized Clinical Trial to Test the Therapeutic Potential of Oral Vicasinabin in Diabetic Retinopathy.

Beatriz G Armendariz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.